CPHXL
gene geneOn this page
Summary
CPHXL (cytoplasmic polyadenylated homeobox like, HGNC:51815) is a protein-coding gene on chromosome 16q23.1, encoding Cytoplasmic polyadenylated homeobox-like protein (A0A1W2PPM1). Transcription factor that acts as activator.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 105371346 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 8 total
- MANE Select transcript:
NM_001355613
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:51815 |
| Approved symbol | CPHXL |
| Name | cytoplasmic polyadenylated homeobox like |
| Location | 16q23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000283755 |
| Ensembl biotype | protein_coding |
| OMIM | 618700 |
| Entrez | 105371346 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000640559
RefSeq mRNA: 1 — MANE Select: NM_001355613
NM_001355613
CCDS: CCDS86543
Canonical transcript exons
ENST00000640559 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003802873 | 75718265 | 75718458 |
| ENSE00003806107 | 75714131 | 75715222 |
| ENSE00003806470 | 75726418 | 75726490 |
Expression profiles
Bgee: expression breadth tissue_specific, 5 present calls, max score 51.77.
Top tissues by expression
117 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 51.77 | silver quality |
| colonic epithelium | UBERON:0000397 | 47.47 | gold quality |
| bone marrow cell | CL:0002092 | 47.06 | gold quality |
| corpus callosum | UBERON:0002336 | 45.48 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 44.88 | gold quality |
| muscle tissue | UBERON:0002385 | 39.51 | gold quality |
| tonsil | UBERON:0002372 | 38.32 | gold quality |
| bone marrow | UBERON:0002371 | 37.31 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.83 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| cortex of kidney | UBERON:0001225 | 33.58 | gold quality |
| mucosa of stomach | UBERON:0001199 | 32.93 | gold quality |
| liver | UBERON:0002107 | 31.30 | gold quality |
| urinary bladder | UBERON:0001255 | 31.07 | gold quality |
| metanephros cortex | UBERON:0010533 | 30.74 | gold quality |
| primary visual cortex | UBERON:0002436 | 30.52 | gold quality |
| kidney | UBERON:0002113 | 30.40 | gold quality |
| testis | UBERON:0000473 | 30.00 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| left testis | UBERON:0004533 | 29.79 | silver quality |
| vermiform appendix | UBERON:0001154 | 29.45 | gold quality |
| blood | UBERON:0000178 | 29.33 | gold quality |
| uterine cervix | UBERON:0000002 | 29.12 | gold quality |
| lymph node | UBERON:0000029 | 28.87 | gold quality |
| popliteal artery | UBERON:0002250 | 28.18 | gold quality |
| tibial artery | UBERON:0007610 | 28.15 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| thyroid gland | UBERON:0002046 | 27.98 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-36552 | yes | 817.01 |
| E-ANND-3 | no | 2.11 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cphx1 | ENSMUSG00000095975 |
| rattus_norvegicus | Cphx1 | ENSRNOG00000025433 |
| drosophila_melanogaster | en | FBGN0000577 |
| drosophila_melanogaster | inv | FBGN0001269 |
| caenorhabditis_elegans | WBGENE00000439 |
Paralogs (3): EN1 (ENSG00000163064), EN2 (ENSG00000164778), CPHXL2 (ENSG00000284484)
Protein
Protein identifiers
Cytoplasmic polyadenylated homeobox-like protein — A0A1W2PPM1 (reviewed: A0A1W2PPM1)
Alternative names: Cytoplasmic polyadenylated homeobox 1
All UniProt accessions (1): A0A1W2PPM1
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor that acts as activator.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_001342542* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR050720 | Engrailed_Homeobox_TFs | Family |
Pfam: PF00046
UniProt features (7 total): compositionally biased region 3, region of interest 2, chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1W2PPM1-F1 | 50.79 | 0.16 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 8 (showing top):
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, WONG_ADULT_TISSUE_STEM_MODULE, chr16q23, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (3): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
178 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CPHXL | CUX2 | O14529 | 247 |
| CPHXL | PLAC9 | Q5JTB6 | 219 |
| CPHXL | TMEM254 | Q8TBM7 | 204 |
| CPHXL | TIMM10 | P62072 | 184 |
| CPHXL | TIMM44 | O43615 | 178 |
| CPHXL | OCA2 | Q04671 | 177 |
| CPHXL | TIMM13 | P62206 | 167 |
| CPHXL | TIMM21 | Q9BVV7 | 166 |
| CPHXL | SDHC | Q99643 | 166 |
| CPHXL | ALDH4A1 | P30038 | 166 |
| CPHXL | NOL9 | Q5SY16 | 166 |
| CPHXL | TIMM50 | Q3ZCQ8 | 166 |
| CPHXL | SDHD | O14521 | 164 |
| CPHXL | DUXB | A0A1W2PPF3 | 163 |
| CPHXL | CHCHD4 | Q8N4Q1 | 161 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GVQ3, A0A1W2PPK0, A0A1W2PPM1, A2A9I7, A6NCI8, A6QQS3, A7XCE8, E9PI22, E9PXT9, O15016, O91083, P09414, P0DMB1, P17923, P18804, P20879, P35965, P49750, Q0P670, Q12857, Q1RMX6, Q32LN6, Q32MG2, Q3B8N5, Q3T016, Q3V0A6, Q4JK59, Q5BI31, Q5T035, Q5ZKH6, Q642A3, Q6AXV6, Q6IMN6, Q6P1W5, Q6PEX7, Q6X4T0, Q80YD3, Q86UF4, Q8BII1, Q8C5V0
Diamond homologs: A0A1W2PPK0, A0A1W2PPM1, A1A546, A1YEY5, A1YFI3, A1YG57, A1YGA2, A2T733, A2T777, A2T7P4, A6NFQ7, G5EC89, L8E946, O14813, O15499, O35690, O42250, O42356, O42357, O42477, O70137, O73917, O75360, O95076, O97670, P0DMV5, P26367, P26630, P29454, P41935, P47237, P47238, P53544, P53545, P53546, P54366, P55813, P55864, P56915, P56916
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
8 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 7 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2682 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:75715214:G:C | F76L | 0.997 |
| 16:75715214:G:T | F76L | 0.997 |
| 16:75715216:A:G | F76L | 0.997 |
| 16:75718379:A:C | F35L | 0.996 |
| 16:75718379:A:T | F35L | 0.996 |
| 16:75718381:A:G | F35L | 0.996 |
| 16:75715215:A:G | F76S | 0.994 |
| 16:75718380:A:G | F35S | 0.994 |
| 16:75715219:A:G | W75R | 0.993 |
| 16:75715219:A:T | W75R | 0.993 |
| 16:75718310:C:A | R58S | 0.992 |
| 16:75718310:C:G | R58S | 0.992 |
| 16:75718356:A:G | L43P | 0.992 |
| 16:75715217:C:A | W75C | 0.991 |
| 16:75715217:C:G | W75C | 0.991 |
| 16:75718299:G:T | A62D | 0.991 |
| 16:75718300:C:G | A62P | 0.991 |
| 16:75718380:A:C | F35C | 0.989 |
| 16:75718302:A:G | L61P | 0.987 |
| 16:75715215:A:C | F76C | 0.983 |
| 16:75715218:C:G | W75S | 0.983 |
| 16:75718343:A:C | F47L | 0.983 |
| 16:75718343:A:T | F47L | 0.983 |
| 16:75718345:A:G | F47L | 0.983 |
| 16:75715194:A:G | L83P | 0.981 |
| 16:75715202:T:A | R80S | 0.979 |
| 16:75715202:T:G | R80S | 0.979 |
| 16:75718289:A:C | F65L | 0.979 |
| 16:75718289:A:T | F65L | 0.979 |
| 16:75718291:A:G | F65L | 0.979 |
dbSNP variants (sampled 300 via entrez): RS1000118828 (16:75724298 T>C), RS1000252403 (16:75728296 T>A,C), RS1000283540 (16:75728085 T>C), RS1000331942 (16:75716135 T>C), RS1000422809 (16:75727704 C>A,G,T), RS1000475054 (16:75727950 A>G), RS1000596690 (16:75724113 A>C,G,T), RS1000694658 (16:75715763 C>T), RS1000917429 (16:75717250 C>A), RS1000961994 (16:75721365 G>A,C), RS1001195576 (16:75727040 A>G), RS1001264911 (16:75717444 G>A,T), RS1001525450 (16:75725128 G>T), RS1001691683 (16:75714510 C>G), RS1001700711 (16:75719587 G>A,C)
Disease associations
OMIM: gene MIM:618700 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.